Instruction for use: Ferric (III) hydroxide polymaltosate + Folic acid

Trade name of the drug – Biofer, Maltofer Fol, Ferri-Fol

The Latin name of the substance Ferric (III) hydroxide polymaltosate + Folic acid

Ferri (III) hydroxydum polymaltosatum+ Acidum folicum (genus. Ferri (III) hydroxydi polymaltosati+ Acidi folici)

Pharmacological groups:

Stimulants of hemopoiesis in combinations

Macro and trace elements in combinations

Model clinical-pharmacological article 1

Pharmacotherapy. Combined drug, stimulates erythropoiesis in iron deficiency anemia. Fe3 + is in the form of a complex hydroxide of the polymaltose complex, which consists of a central lattice formed by Fe3 + nuclei and surrounded by a large number of polymaltose molecules; Has no prooxidant properties, reduces oxidation of LDL and VLDL. Contains 100 mg of Fe3 +. Folic acid - a vitamin B group, stimulates erythropoiesis, participates in the synthesis of amino acids, nucleic acids, purines, pyrimidines, in the exchange of choline.

Indication. Iron deficiency anemia (including against pregnancy, during lactation).

Contraindications. Hypersensitivity, hemochromatosis, hemosiderosis.

Dosing. Dosing and Administration Inside, 1 tablet 2-3 times a day, during or immediately after meals, until the normalization of Hb, then continue taking 1 tablet a day until the end of pregnancy (or lactation). For the prevention of anemia - 1 tablet a day. Duration of treatment of at least 2 months, maintenance therapy - up to 2-3 months.

Side effect. Dyspepsia (sensation of overfilling and pressure in the epigastric region, nausea, vomiting, constipation or diarrhea), dark stool color (due to the excretion of non-sucked Fe and has no clinical significance), allergic reactions.